Metformin Rewires Gut Cells Into Sugar Sinks, New Study Reveals
Researchers have uncovered that the widely prescribed diabetes drug metformin fundamentally alters gut cells, turning them into "sugar sinks." This mechanism leads to lower blood glucose levels by increasing sugar absorption in the intestines.
Key takeaways
- Metformin, a widely used diabetes medication, has been found to alter gut cells, making them absorb more sugar.
- This newly identified mechanism explains how the drug lowers blood glucose levels by creating a "sugar sink" in the intestines.
- The research revisits earlier findings and integrates them with recent discoveries about metformin's effect on cellular respiration.
What Happened
New research indicates that metformin, a common medication for type 2 diabetes, causes intestinal cells to absorb more glucose, effectively transforming the gut into a "sugar sink." This action lowers overall glucose levels in the body.
The findings suggest that metformin prompts gut cells to adopt a different metabolic pathway, which consumes more sugar to generate energy. This occurs when the drug accumulates to high concentrations and inhibits the mitochondria's ability to use oxygen for cell respiration.
Background
While metformin has been a staple for diabetes treatment since its U.S. Food and Drug Administration approval in 1995, its precise mechanism has remained unclear. An early study from 1989 by Jean Girard and colleagues noted that metformin increased glucose absorption in rats' intestines. However, subsequent research predominantly focused on the theory that the drug reduced glucose production by the liver.
Later observations revealed that metformin could cause patients' guts to exhibit increased activity during positron-emission tomography scans using a sugar-consuming tracer. This led scientists to reconsider the role of gut sugar absorption, revisiting earlier research.
Further investigation by Judy Hirst demonstrated that at high concentrations, metformin obstructs the mitochondria's oxygen utilization. Navdeep Chandel's team at Northwestern University sought to reconcile these findings, exploring how increased gut glucose absorption and inhibited mitochondrial oxygen use by metformin work together.
Key Facts
- Metformin is one of the most prescribed medicines in the U.S., primarily for type 2 diabetes.
- Researchers discovered metformin transforms gut cells into a "sugar sink," lowering glucose levels.
- This mechanism involves increased glucose absorption in the intestines.
- Early evidence from 1989 suggested metformin increased glucose absorption in rats.
- After FDA approval in 1995, research largely focused on metformin reducing liver glucose production.
- Radiologists observed increased gut activity in patients taking metformin during PET scans using sugar tracers.
- Judy Hirst found high levels of metformin block mitochondria from using oxygen.
- Northwestern University researchers concluded metformin prompts gut cells to use a pathway that consumes more sugar for energy when oxygen use is blocked.
- This new understanding suggests inhibiting mitochondria may be beneficial in specific contexts.
Sources reviewed
Project Chintan independently synthesized and analyzed information cross-checked across the sources listed above.
Related stories
Karnataka Health Department to Digitize Data Collection by ASHA Workers
NHS Faces 'Summer Surge' Amid Record A&E Visits and Heatwave Pressures
Experts Urge Continuous, Holistic Care for Autism Spectrum Disorder Throughout Life